Literature DB >> 29847508

Domino Liver Transplant in Maple Syrup Urine Disease: Technical Details of Cases in Which the First Surgery Involved a Living Donor.

Karina M O Roda1, Rodrigo Vincenzi1, Eduardo A Fonseca1, Marcel Benavides1, Plínio Turine1, Rogerio C Afonso1, Tassia Tonon2,3, Ida Schwartz2,4,5, Irene K Miura1, Renata Pugliese1, Gilda Porta1, Paulo Chapchap1, Joao Seda Neto1.   

Abstract

BACKGROUND: Data describing the technical aspects of living donor (LD) domino liver transplantation (DLT) in maple syrup urine disease (MSUD) are limited. The largest published series includes only 3 cases. One great challenge of this procedure is to ensure adequate vascular stumps for the LD, the MSUD patient, and the recipient of the domino graft. Here, we describe our experience in 11 cases of LD-DLT in MSUD, highlighting the technical aspects of LD-DLT.
METHODS: From September 2012 to September 2017, 11 patients with MSUD underwent LD liver transplantation at our institution, and MSUD livers were used as domino grafts in 11 children.
RESULTS: (1) MSUD patients: 10 patients received a left lateral segment. The donor's left hepatic vein (HV) was anastomosed to the confluence of the recipient's 3 HVs. No vascular grafts (VG) were required for portal vein (PV) anastomosis. Single arterial anastomosis was performed with microsurgery in 10 of 11 patients. (2) MSUD graft recipients: In 8 cases, HV reconstruction was performed between the graft's HV confluence and the recipient's HV confluence, and in 3 cases, a vena cava triangulation was necessary; 6 MSUD grafts required HV venoplasty. No VG were needed for HV reconstruction. VG were used for PV reconstruction in 3 cases due to sclerotic PV. In 2 cases, double arterial anastomoses were performed in the MSUD liver. All patients remain alive and well.
CONCLUSIONS: Living donor liver transplantation followed by DLT for MSUD is a complex procedure and demands technical refinement. Special attention must be paid to vascular reconstruction.

Entities:  

Mesh:

Year:  2019        PMID: 29847508     DOI: 10.1097/TP.0000000000002300

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  2 in total

Review 1.  Pancreatic cancer: branched-chain amino acids as putative key metabolic regulators?

Authors:  Lenka Rossmeislová; Jan Gojda; Katarína Smolková
Journal:  Cancer Metastasis Rev       Date:  2021-12-28       Impact factor: 9.264

2.  Information and Diagnosis Networks - tools to improve diagnosis and treatment for patients with rare genetic diseases.

Authors:  Taiane Alves Vieira; Franciele Barbosa Trapp; Carolina Fischinger Moura de Souza; Lavínia Schuler Faccini; Laura Bannach Jardim; Ida Vanessa Doederlein Schwartz; Mariluce Riegel; Carmen Regla Vargas; Maira Graeff Burin; Sandra Leistner-Segal; Patrícia Ashton-Prolla; Roberto Giugliani
Journal:  Genet Mol Biol       Date:  2019-06-10       Impact factor: 1.771

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.